Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

NCT03633110

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

NCT01134250

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy) Ancona, Italy
  • Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Meldola (Fc) Meldola, Italy
  • European Institute of Oncology Milan, Italy
  • A.O. UNIVERSITARIA POLICLINICO DI MODENA (Italy) Modena, Italy
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma

NCT02626962

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Hospitalet L'Hospitalet de Llobregat, Spain
  • H. Insular de Canarias Las Palmas de Gran Canaria, Spain
  • Hospital La Paz Madrid, Spain
View Trial Details
Completed

Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma

NCT01927419

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • San Francisco Oncology Associates San Francisco, California, United States
  • Orlando Health Inc Orlando, Florida, United States
  • University Of Louisville Medical Center, Inc., Dba Louisville, Kentucky, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 21 locations
View Trial Details

Related conditions